EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Françoise Grossetête MEP (France), Vice-Chairwoman of the EPP Group in the European Parliament

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Mary Harney, Former Minister for Enterprise, Trade and Employment and Former Minister for Health and Children, Ireland

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Dr Jordi Llinares Garcia, Head of Human Medicines Research and Development Support Division, European Medicines Agency

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Cristian-Silviu Buşoi MEP (EPP Group, Romania), Member of the Civil Liberties, Justice and Home Affairs Committee of the European Parliament

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Françoise Grossetête MEP (France), Vice-Chairwoman of the EPP Group in the European Parliament, Ruxandra Draghia-Akli, Director, Health Directorate, DG Research, European Commission, and Stefan Oelrich, General Manager Germany, Switzerland, Austria, Sanofi

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Pierre Meulien, Executive Director, Innovative Medicines Initiative

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

Nathalie Moll, Secretary General, EuropaBio

EPP Group Hearing 'Towards an integrated EU policy approach for the pharmaceutical sector'

View of the meeting room